How have BVX shares performed in 2024?

BiVictriX Therapeutics' stock was trading at GBX 10.50 at the start of the year. Since then, BVX shares have increased by 14.3% and is now trading at GBX 12. View the best growth stocks for 2024 here .

How do I buy shares of BiVictriX Therapeutics?

Shares of BVX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:BVX

BiVictriX Therapeutics (BVX) Share Price, News & Analysis

→ Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad)

Free BVX Stock Alerts

GBX 12

+0.50 (+4.35%)

(As of 05/3/2024 01:34 PM ET)

Compare

Today's Range: 11
▼
12
50-Day Range: 10.51
▼
12
52-Week Range: 9
▼
16

Volume: 161 shs
Average Volume: 55,756 shs
Market Capitalization: £9.90 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Headlines Insider Trades

Get BiVictriX Therapeutics alerts:

Ad DTI

Special FREE offer on stock hotsheets

These sheets tell you the exact day you should consider buying a stock… And the exact day you should consider selling it… All based on TEN YEARS of historic data and trends. For example, like January 6th through the 12th with Apple… It’s gone up every single year for the last decade. Or like May 26th through June 11th with LULU… Again - it’s gone up every single year for the last decade. Then there’s July 1st through the 21st with Walmart… What happened to WMT?

Click here and I’ll show you

About BiVictriX Therapeutics Stock (LON:BVX)

BiVictriX Therapeutics Plc, a biotechnology company, engages in the development of cancer therapies in the United Kingdom. The company develops Bi-Cygni therapeutics, which are selective for cancer types. Its lead program is BVX001, focuses on acute myeloid leukaemia, as well as develops BVX002 and BVX003 for various blood cancers and solid tumours. BiVictriX Therapeutics Plc was founded in 2016 and is headquartered in Macclesfield, the United Kingdom.

BVX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BVX Stock News Headlines

April 17, 2024 | investing.com

BiVictriX Therapeutics PLC (BVX)

February 15, 2024 | finance.yahoo.com

When Will BiVictriX Therapeutics Plc (LON:BVX) Turn A Profit?

May 7, 2024 | DTI (Ad)

weirdest stock market marches on

For the last few months, Graham Lindman has been urging investors to ignore virtually every stock on the exchange and only focus on the handful of “Apex Stocks” that produce all the wealth. And he sure seems to be right! Because while we’re in an extremely bullish market, it’s not because most companies are doing that well. It’s because a handful of wealth generating juggernauts are yanking the market to all time highs. That’s why this headline called it the “Weirdest bull market”

December 6, 2023 | proactiveinvestors.com

BiVictriX Therapeutics' former chair moves on

October 12, 2023 | reuters.com

BRIEF-Bivictrix Therapeutics PLC Extended Survival Rates Reported With Bvx001 In A Pre-Clinical Model Of Acute Myeloid Leukaemia

October 12, 2023 | proactiveinvestors.com

BiVictriX says latest preclincial leukaemia data could accelerate progress

October 6, 2023 | finance.yahoo.com

BiVictriX Therapeutics appoints combined CFO/CBO to boost out-licensing efforts